Red Light Holland's Q1 2024 Performance: Revenue Soars 53% And Solid Cash Balance

Ontario-based mushrooms producer Red Light Holland Corp. TRUFF filed its quarterly financial statements, management discussion and analysis for the three months ended June 30.

The Numbers:

  • Cash and cash equivalents totaled $12.9 (CA$17.5) million in June 30, 2023 compared to the $13.6 held in March 31, 2023 and to the almost $17 million held by the end of the comparable quarter in 2022.

  • Quarterly revenue of $885.396 vs. $578.451 in the same period in 2022, a 53.1% increase; and gross profit of $385.417 vs. $213.071, representing an 80.9% increase jump from one year to the next. 

  • Quarter’s operating expenses of $1.9 million vs. $1.2 in the same period in 2022. 

  • Quarterly net loss of $1.4 million vs. $1.1 million in the comparable period in 2022.

CEO Todd Shapiro says the team remains confident in its “everything mushroom company” growth strategy while also keeping a focus on emerging psilocybin markets, “as our finger is most definitely on the psychedelic pulse." 

Shapiro also says some commencement dates have effectively been pushed back for planning and outlook perfecting purposes. 

“Red Light is clearly a well-rounded and cautious company as it relates to careful spending and patient growth,” he said, adding the team is “very transparent and available” for shareholders reach on questions regarding the company’s brands, launches, the Peterborough farm, M&A activity, and the novel psilocybin microdosing capsules for Australasian distribution. 

Of the latter, Shapiro assures the team would provide updates “in the very, and I mean the very near future!"

CFO David Ascott says Red Light’s financial position and liquidity remain strong, with the company holding enough capital to fund its ongoing business development and future growth and expansion plans “for the foreseeable future.” 

The team has reportedly been putting its excess cash to good use through government-issued GICs, “taking advantage of the current market interest rates to increase our return on investment related to these funds" says Ascott.

Into the cannabis industry instead? Then our upcoming Cannabis Capital Conference is where you ought to be! Whether to close your deals or just get acquainted with the sector’s best, come join us this Sept. 27-28 in Chicago for our 17th edition! Tickets HERE.

Photo: Benzinga edit with photo by PublicDomainPictures and sergeitokmakov by Pixabay.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksPsychedelicsGuidanceMarketsfinancial resultsPsilocybin programPsychedelic-Assisted Therapies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...